Format

Send to

Choose Destination
Curr Opin Pharmacol. 2013 Feb;13(1):16-22. doi: 10.1016/j.coph.2012.09.002. Epub 2012 Sep 20.

Maintenance of retinal ganglion cell mitochondrial functions as a neuroprotective strategy in glaucoma.

Author information

1
Fundación de Investigación Oftalmológica, Avda. Doctores Fernández-Vega 34, E-33012 Oviedo, Asturias, Spain. Neville.osborne@eye.ox.ac.uk

Abstract

Loss of vision in glaucoma occurs because retinal ganglion cells (RGCs) die. RGCs have probably more mitochondria than any other neurone in the CNS. It is proposed that stress to mitochondria of individual RGCs is a major trigger of the disease and also provides an explanation why different RGCs die at different times. Pharmacological agents that can maintain mitochondrial functions, in particular to attenuate oxidative stress and to sustain energy production, might therefore provide a novel way of slowing down RGC death and help in the treatment of glaucoma.

PMID:
22999653
DOI:
10.1016/j.coph.2012.09.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center